Showing 1 - 8 results of 8 for search 'Galli, L', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study by Spagnuolo V, Galli L, Poli A, Bigoloni A, Fumagalli L, Gianotti N, Nozza S, Ferrari D, Locatelli M, Lazzarin A, Castagna A
Published 2019-01-01
Article -
5
-
6
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum] by Ranzenigo M, Gianotti N, Galli L, Poli A, Mastrangelo A, Bruzzesi E, Chiurlo M, Nozza S, Bossolasco S, Spagnuolo V, Mancusi D, Termini R, Carini E, Lazzarin A, Castagna A
Published 2022-10-01
Article -
7
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study by Spagnuolo V, Voarino M, Tonelli M, Galli L, Poli A, Bruzzesi E, Racca S, Clementi N, Oltolini C, Tresoldi M, Rovere Querini P, Dagna L, Zangrillo A, Ciceri F, Clementi M, Castagna A
Published 2022-10-01
Article -
8
Response to combination antiretroviral therapy: variation by age. by Sabin, C, Smith, C, d'Arminio Monforte, A, Battegay, M, Gabiano, C, Galli, L, Geelen, S, Gibb, D, Guiguet, M, Judd, A, Leport, C, Dabis, F, Pantazis, N, Porter, K, Raffi, F, Thorne, C, Torti, C, Walker, S, Warszawski, J, Wintergerst, U, Chene, G, Lundgren, J
Published 2008Journal article